Neuropharmacology Research Laboratory, Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Bandar Sunway, 47500 Selangor, Malaysia.
Infection and Immunity Research Laboratory, Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Bandar Sunway, 47500 Selangor Malaysia.
ACS Chem Neurosci. 2020 Nov 4;11(21):3488-3498. doi: 10.1021/acschemneuro.0c00431. Epub 2020 Oct 16.
Dysbiosis of gut microbiota may lead to a range of diseases including neurological disorders. Thus, it is hypothesized that regulation of the intestinal microbiota may prevent or treat epilepsy. The purpose of this systematic review is to evaluate the evidence investigating the relationship between gut microbiota and epilepsy and possible interventions. A systematic review of the literature was done on four databases (PubMed, Scopus, EMBASE, and Web of Science). Study selection was restricted to original research articles while following the PRISMA guidelines. Six studies were selected. These studies cohesively support the interaction between gut microbiota and epileptic seizures. Gut microbiota analysis identified increases in Firmicutes, Proteobacteria, Verrucomicrobia, and Fusobacteria with decreases in Bacteroidetes and Actinobacteria in epileptic patients. Ketogenic diet, probiotics, and fecal microbiota transplantation (FMT) improved the dysbiosis of the gut microbiota and seizure activity. However, the studies either had a small sample size, lack of subject variability, or short study or follow-up period, which may question their reliability. Nevertheless, these limited studies conclusively suggest that gut microbiota diversity and dysbiosis may be involved in the pathology of epilepsy. Future studies providing more reliable and in depth insight into the gut microbial community will spark promising alternative therapies to current epilepsy treatment.
肠道微生物失调可能导致一系列疾病,包括神经紊乱。因此,有人假设肠道微生物群的调节可能预防或治疗癫痫。本系统综述的目的是评估调查肠道微生物群与癫痫之间关系以及可能的干预措施的证据。在四个数据库(PubMed、Scopus、EMBASE 和 Web of Science)上进行了文献系统综述。研究选择仅限于原始研究文章,并遵循 PRISMA 指南。选择了六项研究。这些研究一致支持肠道微生物群与癫痫发作之间的相互作用。肠道微生物组分析发现,癫痫患者的厚壁菌门、变形菌门、疣微菌门和梭杆菌门增加,拟杆菌门和放线菌门减少。生酮饮食、益生菌和粪便微生物群移植(FMT)改善了肠道微生物群的失调和癫痫发作活动。然而,这些研究要么样本量小,要么缺乏受试者变异性,要么研究或随访时间短,这可能使其可靠性受到质疑。尽管如此,这些有限的研究明确表明,肠道微生物多样性和失调可能与癫痫的发病机制有关。未来的研究将更深入地了解肠道微生物群落,为目前的癫痫治疗提供更有前途的替代疗法。